Characterization of the lytic-lysogenic switch of the lactococcal bacteriophage Tuc2009

Autor: Kenny, JG, Leach, S, de la Hoz, AB, Venema, G, Kok, J, Fitzgerald, GF, Nauta, A, Alonso, JC, van Sinderen, D, Kenny, John G., Hoz, Ana B. de la, Fitzgerald, Gerald F., Alonso, Juan C.

Publikováno v: Virology, 347(2), 434-446. ACADEMIC PRESS INC ELSEVIER SCIENCE

Tuc2009 is a temperate bacteriophage of Lactococcus lactis subsp. cremoris UC509 which encodes a CI- and Cro-type lysogenic-lytic switch region. A helix-swap of the 0 helices of the closely related Cl-type proteins from the lactococcal phages r1t and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de5bb987166cc5769ee5a6a70bf8f20c
https://hdl.handle.net/11370/dd8c5ce5-9ae8-49e0-813c-83e55e926503

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genetic profile of a large Spanish cohort with hypercalcemia.

Autor: García-Castaño A; Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., Madariaga L; Pediatric Nephrology Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., Gómez-Conde S; Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., González P; Endocrinology and Nutrition Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, EndoERN, Barakaldo, Bizkaia, Spain., Grau G; Pediatric Endocrinology Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, EndoERN, Barakaldo, Bizkaia, Spain., Rica I; Pediatric Endocrinology Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., de Nanclares GP; Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., De la Hoz AB; Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., Aguayo A; Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., Martínez R; Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., Urrutia I; Biobizkaia Health Research Institute, Hospital Universitario Cruces, CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., Gaztambide S; Endocrinology and Nutrition Department, Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain., Castaño L; Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), CIBERDEM, CIBERER, EndoERN, Barakaldo, Bizkaia, Spain.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Mar 22; Vol. 15, pp. 1297614. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).

Five patients with disorders of calcium metabolism presented with GCM2 gene variants.

Autor: García-Castaño A; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Plaza de Cruces, Barakaldo, 48903, Bizkaia, Spain. alejandro.garciacastano@osakidetza.eus., Madariaga L; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Pediatric Nephrology Department, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), Bizkaia, Spain., Gómez-Conde S; Biocruces Bizkaia Health Research Institute, Bizkaia, Spain., Cordo CLR; Pediatric Endocrinology Department, Hospital Álvaro Cunqueiro, EOXI, Vigo, Spain., López-Iglesias M; Endocrinology Department, Hospital General La Mancha Centro, Ciudad Real, Spain., Garcia-Fernández Y; Endocrinology and Nutrition Department, OSI Barrualde-Galdakao, Bizkaia, Spain., Martín A; Biocruces Bizkaia Health Research Institute, Endocrinology and Nutrition Department, Hospital Universitario Cruces, Bizkaia, Spain., González P; Biocruces Bizkaia Health Research Institute, Endocrinology and Nutrition Department, Hospital Universitario Cruces, Bizkaia, Spain., Goicolea I; Biocruces Bizkaia Health Research Institute, Endocrinology and Nutrition Department, Hospital Universitario Cruces, Bizkaia, Spain., de Nanclares GP; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Hospital Universitario Cruces, Bizkaia, Spain., De la Hoz AB; Biocruces Bizkaia Health Research Institute, CIBERER, Bizkaia, Spain., Aguayo A; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Hospital Universitario Cruces, Bizkaia, Spain., de LaPiscina IM; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Plaza de Cruces, Barakaldo, 48903, Bizkaia, Spain., Martínez R; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Plaza de Cruces, Barakaldo, 48903, Bizkaia, Spain., Saso L; Biocruces Bizkaia Health Research Institute, Bizkaia, Spain., Urrutia I; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Plaza de Cruces, Barakaldo, 48903, Bizkaia, Spain., Velasco O; Biocruces Bizkaia Health Research Institute, Bizkaia, Spain., Castaño L; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Endocrinology and Nutrition Department, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), Bizkaia, Spain., Gaztambide S; Biocruces Bizkaia Health Research Institute, CIBERDEM, CIBERER, Endocrinology and Nutrition Department, Hospital Universitario Cruces, University of the Basque Country (UPV/EHU), Bizkaia, Spain.

Publikováno v: Scientific reports [Sci Rep] 2021 Feb 03; Vol. 11 (1), pp. 2968. Date of Electronic Publication: 2021 Feb 03.